Shelter Pharma (BOM:543963) ROCE %: 18.03% (As of Mar. 2026)


BOM:543963 Shelter Pharma Ltd BOM:543963
66 GF Score
Price ₹29.05
GF Value ₹57.84
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Shelter Pharma ROCE %?

Shelter Pharma BOM:543963 +0.66% 66 ROCE % is 18.03% as of Mar. 2026. GuruFocus rates BOM:543963 with a GF Score™ of 66/100 and a GF Value™ of ₹57.84 (Possible Value Trap). The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Shelter Pharma's annualized ROCE % for the quarter that ended in Mar. 2026 was 18.03%.

Shelter Pharma  (BOM:543963) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Shelter Pharma ROCE % Related Terms

Shelter Pharma ROCE % Historical Data

* Premium members only.

The historical data trend for Shelter Pharma's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shelter Pharma ROCE % Chart

Shelter Pharma Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial 31.17 57.43 32.89 24.47 20.39

Shelter Pharma Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 25.02 25.00 23.80 23.09 18.03
BOM:543963
66GF Score
Shelter Pharma Ltd BOM:543963
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shelter Pharma ROCE % Calculation

Shelter Pharma's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=123.323/( ( (483.355 - 46.286) + (842.329 - 69.997) )/ 2 )
=123.323/( (437.069+772.332)/ 2 )
=123.323/604.7005
=20.39 %

Shelter Pharma's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Sep. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Sep. 2025 )(Q: Mar. 2026 )
=125.11/( ( (668.954 - 53.15) + (842.329 - 69.997) )/ 2 )
=125.11/( ( 615.804 + 772.332 )/ 2 )
=125.11/694.068
=18.03 %

(1) Note: The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 18.03% mean?
Shelter Pharma (BOM:543963) has a ROCE % of 18.03% as of Mar. 2026.
Is Shelter Pharma's ROCE % too high?
Shelter Pharma's current ROCE % is 18.03%. The Drug Manufacturers industry median ROCE % is 7.03. Shelter Pharma's value of 18.03% is 156.5% above this industry median. Overall, Shelter Pharma has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Shelter Pharma's ROCE % compare to ZTS and UTHR?
Shelter Pharma's ROCE % of 18.03% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.03. Shelter Pharma's value of 18.03% is 156.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.03, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shelter Pharma's current ROCE % of 18.03% is 156.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shelter Pharma's current ROCE % is 18.03%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shelter Pharma stock overvalued right now?
Based on GuruFocus' analysis, Shelter Pharma (BOM:543963) is currently considered Possible Value Trap. The stock's GF Value™ is ₹57.84, compared to a current price of ₹29.05 — trading 49.8% below its estimated fair value. The current ROCE % is 18.03% and 156.5% above the Drug Manufacturers industry median of 7.03. Shelter Pharma's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Shelter Pharma (BOM:543963), the current ROCE % is 18.03% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shelter Pharma (BOM:543963) Overvalued in 2026?

Based on GuruFocus' analysis, Shelter Pharma stock appears to be undervalued. The current stock price of ₹29.05 is trading 49.8% below its estimated GF Value™ of ₹57.84. GuruFocus considers Shelter Pharma to be Possible Value Trap.

Key valuation signals for BOM:543963:

  • ROCE %: 18.03%
  • GF Value™: ₹57.84 vs. price of ₹29.05 (49.8% below fair value)
  • GF Score™: 66/100 with 5 warning signs
  • Industry Position: 156.5% above the Drug Manufacturers median

No single metric tells the full story. See the BOM:543963 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shelter Pharma Business Description

Address Ashram Road, 5th Floor, 501 Sakar 4, Opposite MJ Library, Paldi, Ellisbridge, Ahmedabad, GJ, IND, 380006
Shelter Pharma Ltd focuses in manufacturing herbal products with a well-built presence in Human Pharma as well as the Veterinary space. It is present in majority of the non-critical segments of human and veterinary pharma through its well-spread portfolio. Its products include tablets, syrups, baby drops, barley water, oils, powders, ointments, etc.
66GF Score

Get the complete analysis for BOM:543963

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹29.05
Price
₹57.84
GF Value